• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

再生医学在儿科肾脏病学中的进展和潜力。

Advances and potential of regenerative medicine in pediatric nephrology.

机构信息

Department of Nephrology and Hypertension, Regenerative Medicine Center Utrecht, University Medical Center Utrecht, Utrecht, The Netherlands.

Department of Development and Regeneration, Cluster Woman and Child, Laboratory of Pediatric Nephrology, KU Leuven, Leuven, Belgium.

出版信息

Pediatr Nephrol. 2024 Feb;39(2):383-395. doi: 10.1007/s00467-023-06039-0. Epub 2023 Jul 3.

DOI:10.1007/s00467-023-06039-0
PMID:37400705
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10728238/
Abstract

The endogenous capacity of the kidney to repair is limited, and generation of new nephrons after injury for adequate function recovery remains a need. Discovery of factors that promote the endogenous regenerative capacity of the injured kidney or generation of transplantable kidney tissue represent promising therapeutic strategies. While several encouraging results are obtained after administration of stem or progenitor cells, stem cell secretome, or extracellular vesicles in experimental kidney injury models, very little data exist in the clinical setting to make conclusions about their efficacy. In this review, we provide an overview of the cutting-edge knowledge on kidney regeneration, including pre-clinical methodologies used to elucidate regenerative pathways and describe the perspectives of regenerative medicine for kidney patients.

摘要

肾脏自身的修复能力有限,因此需要产生新的肾单位来实现足够的功能恢复。发现能够促进受损肾脏内源性再生能力或产生可移植肾组织的因子代表了很有前途的治疗策略。虽然在实验性肾损伤模型中给予干细胞或祖细胞、干细胞分泌组或细胞外囊泡后获得了一些令人鼓舞的结果,但在临床环境中几乎没有关于其疗效的结论性数据。在这篇综述中,我们概述了肾脏再生的最新知识,包括用于阐明再生途径的临床前方法,并描述了再生医学在肾脏疾病患者中的应用前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1620/10728238/ea717517c633/467_2023_6039_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1620/10728238/c71e3a0f3232/467_2023_6039_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1620/10728238/ea717517c633/467_2023_6039_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1620/10728238/c71e3a0f3232/467_2023_6039_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1620/10728238/ea717517c633/467_2023_6039_Fig2_HTML.jpg

相似文献

1
Advances and potential of regenerative medicine in pediatric nephrology.再生医学在儿科肾脏病学中的进展和潜力。
Pediatr Nephrol. 2024 Feb;39(2):383-395. doi: 10.1007/s00467-023-06039-0. Epub 2023 Jul 3.
2
Regenerative medicine for the kidney: renotropic factors, renal stem/progenitor cells, and stem cell therapy.肾脏再生医学:促肾因子、肾干/祖细胞与干细胞疗法
Biomed Res Int. 2014;2014:595493. doi: 10.1155/2014/595493. Epub 2014 May 8.
3
[Regenerative medicine in nephrology].[肾脏病学中的再生医学]
Nihon Rinsho. 2006 Feb;64 Suppl 2:7-13.
4
Regenerative pharmacology for the treatment of acute kidney injury: Skeletal muscle stem/progenitor cells for renal regeneration?用于治疗急性肾损伤的再生药理学:骨骼肌干/祖细胞用于肾脏再生?
Pharmacol Res. 2016 Nov;113(Pt B):802-807. doi: 10.1016/j.phrs.2016.03.014. Epub 2016 Mar 18.
5
Stem cell secretome as a new booster for regenerative medicine.干细胞 secretome 作为再生医学的新助推器。
Biosci Trends. 2019;13(4):299-307. doi: 10.5582/bst.2019.01226.
6
Progress toward the Clinical Application of Mesenchymal Stromal Cells and Other Disease-Modulating Regenerative Therapies: Examples from the Field of Nephrology.间质基质细胞和其他疾病调节性再生疗法临床应用的进展:肾脏病学领域的实例。
Kidney360. 2021 Mar;2(3):542-557. doi: 10.34067/KID.0005692020.
7
Regenerative medicine in kidney disease: where we stand and where to go.肾脏疾病中的再生医学:现状与展望。
Pediatr Nephrol. 2018 Sep;33(9):1457-1465. doi: 10.1007/s00467-017-3754-9. Epub 2017 Jul 22.
8
Concise Review: Understanding the Renal Progenitor Cell Niche In Vivo to Recapitulate Nephrogenesis In Vitro.简要综述:了解体内肾祖细胞生态位以在体外重现肾发生
Stem Cells Transl Med. 2015 Dec;4(12):1463-71. doi: 10.5966/sctm.2015-0104. Epub 2015 Oct 22.
9
Progenitor/stem cells in renal regeneration and mass lesions.肾脏再生与肿块性病变中的祖细胞/干细胞
Int Urol Nephrol. 2014 Nov;46(11):2227-36. doi: 10.1007/s11255-014-0821-z. Epub 2014 Sep 3.
10
Kidney regeneration and stem cells.肾脏再生与干细胞。
Anat Rec (Hoboken). 2014 Jan;297(1):129-36. doi: 10.1002/ar.22801. Epub 2013 Dec 2.

引用本文的文献

1
Preserving nephron number in children after preterm birth: a top priority.保留早产儿出生后肾单位数量:重中之重。
Pediatr Nephrol. 2025 Sep 9. doi: 10.1007/s00467-025-06945-5.
2
Developmental Causes of Focal Segmental Glomerulosclerosis.局灶节段性肾小球硬化的发育成因。
Glomerular Dis. 2024 Mar 14;4(1):95-104. doi: 10.1159/000538345. eCollection 2024 Jan-Dec.
3
Silymarin and MSC-exosomes ameliorate thioacetamide-evoked renal fibrosis by inhibiting TGF-β/SMAD pathway in rats.水飞蓟宾和 MSC-exosomes 通过抑制 TGF-β/SMAD 通路减轻硫代乙酰胺诱导的大鼠肾纤维化。

本文引用的文献

1
Extracellular Vesicles in Kidney Diseases: Moving Forward.肾脏疾病中的细胞外囊泡:展望未来。
Kidney360. 2023 Feb 1;4(2):245-257. doi: 10.34067/KID.0001892022. Epub 2022 Dec 18.
2
Tubuloid culture enables long-term expansion of functional human kidney tubule epithelium from iPSC-derived organoids.类肾小管培养可实现从 iPSC 衍生类器官中扩增功能正常的人肾小管上皮细胞。
Proc Natl Acad Sci U S A. 2023 Feb 7;120(6):e2216836120. doi: 10.1073/pnas.2216836120. Epub 2023 Feb 1.
3
Activated SOX9+ renal epithelial cells promote kidney repair through secreting factors.
Mol Biol Rep. 2024 Apr 18;51(1):529. doi: 10.1007/s11033-024-09343-6.
激活的 SOX9+ 肾上皮细胞通过分泌因子促进肾脏修复。
Cell Prolif. 2023 Apr;56(4):e13394. doi: 10.1111/cpr.13394. Epub 2023 Jan 4.
4
Safety of Stromal Vascular Fraction Cell Therapy for Chronic Kidney Disease of Unknown Cause (Mesoamerican Nephropathy).基质血管成分细胞治疗不明原因慢性肾脏病(中美洲肾病)的安全性。
Stem Cells Transl Med. 2023 Jan 30;12(1):7-16. doi: 10.1093/stcltm/szac080.
5
3D Human iPSC Blood Vessel Organoids as a Source of Flow-Adaptive Vascular Cells for Creating a Human-Relevant 3D-Scaffold Based Macrovessel Model.3D人诱导多能干细胞血管类器官作为用于构建基于人源化3D支架的大血管模型的血流适应性血管细胞来源
Adv Biol (Weinh). 2023 Jan;7(1):e2200137. doi: 10.1002/adbi.202200137. Epub 2022 Oct 27.
6
Organoid-on-a-chip model of human ARPKD reveals mechanosensing pathomechanisms for drug discovery.人源常染色体显性遗传多囊肾病类器官芯片模型揭示了用于药物发现的机械感知发病机制。
Sci Adv. 2022 Sep 23;8(38):eabq0866. doi: 10.1126/sciadv.abq0866. Epub 2022 Sep 21.
7
Single-cell transcriptomics reveals common epithelial response patterns in human acute kidney injury.单细胞转录组学揭示了人类急性肾损伤中常见的上皮细胞反应模式。
Genome Med. 2022 Sep 9;14(1):103. doi: 10.1186/s13073-022-01108-9.
8
Urinary single-cell sequencing captures kidney injury and repair processes in human acute kidney injury.尿单细胞测序捕获人类急性肾损伤中的肾损伤和修复过程。
Kidney Int. 2022 Dec;102(6):1359-1370. doi: 10.1016/j.kint.2022.07.032. Epub 2022 Aug 29.
9
Analyzing cell-type-specific dynamics of metabolism in kidney repair.分析肾脏修复中细胞类型特异性代谢的动态变化。
Nat Metab. 2022 Sep;4(9):1109-1118. doi: 10.1038/s42255-022-00615-8. Epub 2022 Aug 25.
10
De novo SIX2 activation in human kidneys treated with neonatal kidney stem/progenitor cells.在经新生儿肾干/祖细胞处理的人类肾脏中,SIX2 被从头激活。
Am J Transplant. 2022 Dec;22(12):2791-2803. doi: 10.1111/ajt.17164. Epub 2022 Aug 11.